Limited (“ HUTCHMED ”) (Nasdaq/AIM:?HCM; HKEX:?13) today announces that it will receive a US$20 million milestone payment from its partner Takeda (TSE:?4502/?NYSE:?TAK), triggered by reaching over ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it will receive a US$20 ...

Upcoming earnings releases in Asia, as well as the rest of the world, also added to the wait-and-see mood. On Wall Street, ...

Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the end of this year ...

Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...

Learn how to grow your wealth through smart investing strategies and financial planning in this informative article by a ...

Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up ...

Eli Lilly expects to start selling its weight-loss drug in Hong Kong as early as the end of this year, Bloomberg News ...

Tsui Wah Lang Kwai Fong is set to open on Wednesday, 23 October. Tsui Wah Lang Kwai Fong, G/F, Silver Fortune Plaza, 1 Wellington Street, Central, Hong Kong, www.tsuiwah.com Gaia Group’s lavish new ...

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The U.S. pharmaceutical company and ...

Last week, the Food and Drug Administration declared an end to the shortage of Eli Lilly’s tirzepatide, sold under the brand name Mounjaro for diabetes and Zepbound for obesity. The move was a ...